Clinical Guide

How to Integrate PrEP Into Psychiatric Care for Bipolar Disorder

How can clinicians incorporate HIV preexposure prophylaxis management into psychiatric care for patients with bipolar disorder?

Many patients with bipolar disorder have regular psychiatric follow-up but inconsistent primary care access, and psychiatry-only care in this study was associated with higher odds of HIV diagnosis. The article argues that psychiatric practice can be a practical setting for expanding PrEP because PrEP follow-up cadence overlaps with routine bipolar disorder medication monitoring and visit structure.

  1. Use psychiatric visits as an HIV prevention touchpoint

    Incorporate HIV prevention review into routine bipolar disorder follow-up instead of assuming primary care will manage it. The article highlights psychiatric care as a fundamental point of health care contact for people with serious mental illness and identifies psychiatry as a setting where PrEP could be expanded.

  2. Coordinate with primary care when both settings are involved

    When a patient has access to both psychiatry and primary care, use that dual engagement to support PrEP delivery. In this study, having both psychiatrist and primary care encounters was associated with higher odds of PrEP prescription compared with primary care-only follow-up.

  3. Plan follow-up around the required PrEP visit schedule

    Build monitoring expectations into the care plan from the start. The discussion states that oral PrEP would require at least 4 annual primary care visits for laboratory testing and refills, while long-acting cabotegravir PrEP would require at least 6 injection visits per year.

  4. Align PrEP monitoring with bipolar disorder medication monitoring

    Where feasible, combine PrEP-related laboratory follow-up with the monitoring infrastructure already used for bipolar disorder pharmacotherapy. The article notes that patients treated with lithium or valproic acid already undergo regular laboratory surveillance, and that kidney function, lipids, and HIV status monitoring for PrEP may be integrated into this ongoing management.

  5. Consider long-acting PrEP for patients suited to injection-based care

    For patients who may struggle with adherence to a daily oral regimen, consider whether long-acting injectable PrEP could fit their care pattern. The article notes overlap between psychiatric experience with long-acting antipsychotics and the cadence of long-acting PrEP, including 8-week cabotegravir injections and twice-yearly lenacapavir.

  6. Leverage PrEP training and consultation resources

    If knowledge gaps are a barrier, pursue structured training before adding PrEP prescribing to psychiatric practice. The article specifically identifies the National PrEP Curriculum as a freely available educational resource and the National Clinician Consultation Center as a source of free clinician-to-clinician consultation.

Clinical Considerations

  • The study did not test a psychiatric PrEP implementation protocol directly; its recommendations about integration into psychiatric care are based on observed care patterns and the authors' discussion.
  • Most PrEP prescriptions are currently managed by primary care providers, so psychiatric integration may still require cross-setting coordination.
  • Use of long-acting antipsychotics is low in practice, so coadministration with long-acting PrEP may be feasible for some patients but not broadly applicable to all.
  • The claims database did not capture PrEP obtained through self-pay or charitable programs, so clinical workflows based on these findings may underestimate existing PrEP access outside insured care.

Bottom Line

Psychiatric care for bipolar disorder is a practical place to deliver or coordinate PrEP because the visit frequency, laboratory monitoring, and injection infrastructure can overlap with routine psychiatric management.

Read full article
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.